BSE Live
Oct 09, 16:01Prev. Close
2727.80
Open Price
2735.65
Bid Price (Qty.)
2721.85 (200)
Offer Price (Qty.)
2828.00 (5)
NSE Live
Oct 09, 15:55Prev. Close
2729.60
Open Price
2730.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2761.00 (100)
Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 1,243.74 | 809.04 | 837.49 | 2,470.04 | 722.33 | |
Net CashFlow From Operating Activities | 1,280.03 | 578.93 | 487.94 | 819.79 | 594.87 | |
Net Cash Used In Investing Activities | -36.53 | 14.97 | 805.19 | -419.66 | 407.57 | |
Net Cash Used From Financing Activities | -769.42 | -561.49 | -1,544.18 | -524.24 | -695.56 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 474.07 | 32.41 | -251.05 | -124.11 | 306.87 | |
Cash And Cash Equivalents Begin of Year | 62.15 | 29.74 | 280.79 | 404.90 | 98.03 | |
Cash And Cash Equivalents End Of Year | 536.22 | 62.15 | 29.74 | 280.79 | 404.90 |
12.08.2025
GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y
01.08.2025
GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y
29.06.2025
01.06.2025